Literature DB >> 19703890

Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation.

Azusa Kitao1, Yoh Zen, Osamu Matsui, Toshifumi Gabata, Yasuni Nakanuma.   

Abstract

PURPOSE: To clarify the changes that occur in drainage vessels of dysplastic nodules and hepatocellular carcinoma (HCC) during hepatocarcinogenesis by using computed tomography (CT) during arterial portography (CTAP) and CT during hepatic arteriography (CTHA), with histologic findings as the reference standard.
MATERIALS AND METHODS: Institutional ethics committee approval and informed consent were obtained. According to the findings at CTAP and CTHA, 46 surgically resected hepatocellular nodules were classified into three types: type A (n = 18) (equivalent or decreased portal perfusion compared with background liver at CTAP, decreased arterial perfusion, and no corona enhancement [perinodular contrast material drainage] at CTHA), type B (n = 13) (no portal perfusion, increased arterial perfusion, and thin (< or = 2-mm) corona enhancement), or type C (n = 15) (no portal perfusion, increased arterial perfusion, and thick (> 2-mm) corona enhancement). We compared the histopathologic features and microangioarchitecture between the types.
RESULTS: Type A nodules histologically consisted of dysplastic nodules and well-differentiated HCC; type B and C nodules were moderately differentiated HCC. Replacing growth was commonly observed in type A nodules, whereas compressing growth was more frequently seen in types B and C. Sixty percent of type C nodules had a fibrous capsule. There were significantly fewer intranodular hepatic veins in types B and C. Serial pathologic slices demonstrated continuity from intranodular capillarized sinusoids to hepatic veins in type A nodules and to surrounding hepatic sinusoids in type B nodules. In type C nodules, intranodular capillarized sinusoids were connected to extranodular portal veins either directly or through portal venules within the fibrous capsule.
CONCLUSION: Drainage vessels of HCC change from hepatic veins to hepatic sinusoids and then to portal veins during multistep hepatocarcinogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19703890     DOI: 10.1148/radiol.2522081414

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  58 in total

1.  Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histological grading.

Authors:  X Q Pei; L Z Liu; M Liu; W Zheng; F Han; A H Li; M Y Cai
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

Review 2.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

3.  Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?

Authors:  Sieh-Yang Lee; Hsin-You Ou; Chun-Yen Yu; Tung-Liang Huang; Leo Leung-Chit Tsang; Yu-Fan Cheng
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

4.  Hepatoma feeding arteriogram created by CT during aortography using IVR 64-multidetector-row CT for catheterization in transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Hiroki Minamiguchi; Nobuyuki Kawai; Morio Sato; Akira Ikoma; Hiroki Sanda; Kouhei Nakata; Fumihiro Tanaka; Motoki Nakai; Tetsuo Sonomura; Kazuhiro Murotani; Seiki Hosokawa; Tadayoshi Nishioku
Journal:  Jpn J Radiol       Date:  2013-05-09       Impact factor: 2.374

Review 5.  Efficacy of cone-beam computed tomography during transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Shiro Miyayama; Masashi Yamashiro; Yuki Hattori; Nobuaki Orito; Ken Matsui; Kazunobu Tsuji; Miki Yoshida; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2011-07-24       Impact factor: 2.374

6.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

Review 7.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

8.  Optimal injection rate and volume of contrast medium for observing hemodynamics of a hepatocellular carcinoma structure model.

Authors:  Kazuhiro Murotani; Nobuyuki Kawai; Morio Sato; Hiroki Minamiguchi; Motoki Nakai; Tetsuo Sonomura; Seiki Hosokawa; Tadayoshi Nishioku
Journal:  Radiol Phys Technol       Date:  2012-08-08

9.  Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.

Authors:  Katsuhiro Sano; Tomoaki Ichikawa; Utaroh Motosugi; Shintaro Ichikawa; Hiroyuki Morisaka; Nobuyuki Enomoto; Masanori Matsuda; Hideki Fujii
Journal:  Eur Radiol       Date:  2016-06-02       Impact factor: 5.315

10.  Efficacy of early treatment on 52 patients with preneoplastic hepatitis B virus-associated hepatocellular carcinoma by compound Phyllanthus Urinaria L.

Authors:  Guang-dong Tong; Xi Zhang; Da-qiao Zhou; Chun-shan Wei; Jin-song He; Chun-ling Xiao; Xin-liang Liu; Ying-jun Zheng; Si-nuan Chen; Hai-hong Tang
Journal:  Chin J Integr Med       Date:  2013-03-25       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.